Browsing Harvard Medical School by Keyword "immune checkpoint inhibitor"
Now showing items 1-1 of 1
-
Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model
(Impact Journals LLC, 2016)Advances in the treatment of metastatic clear cell renal cell carcinoma (ccRCC) have led to improved progression-free survival of many patients; however the therapies are toxic, rarely achieve durable long-term complete ...